Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone in Cerebral Vasospasm
NCT02712788Phase 2Terminated
- Sponsor
- Indiana University
- Start
- Apr 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cerebral vasospasm comparing Milrinone with Placebo (2 arms). Primary endpoint: Modified Rankin Scale at 6 months. Started Apr 2016; status: terminated.
02
Drugs
milrinone
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT02712788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712788.